Personnel Changes

TOKYO, February 3, 2022 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced the following personnel changes, effective March 29 and April 1, 2022 respectively.

[Details of Personnel Changes]
Effective March 29, 2022

Directors

Name	New Responsibilities	Current Responsibilities
Osamu Okuda	Representative Director, President Chief Executive Officer (CEO) Supervisory responsibility for Corporate Planning, Partnering, External Affairs and Audit In charge of Corporate Planning Dept., External Affairs Dept., and Audit Dept.	Representative Director, President Chief Executive Officer (CEO) Supervisory responsibility for Clinical Development, Pharmaceutical Technology, Drug Safety, Medical Affairs, Marketing & Sales and Foundation Medicine
Hisafumi Yamada	Director, Executive Vice President Supervisory responsibility for Project & Lifecycle Management (R&D), Research, Translational Research, Clinical Development and Pharmaceutical Technology	Executive Vice President Supervisory responsibility for Project & Lifecycle Management (R&D), Research and Translational Research
Toshiaki Itagaki	Director, Executive Vice President Chief Financial Officer (CFO) Supervisory responsibility for Finance & Accounting, Corporate Communication and Purchasing Head of Finance Supervisory Div.	Executive Vice President Chief Financial Officer (CFO) Supervisory responsibility for Finance & Accounting, Corporate Communication, Purchasing and Digital Transformation Head of Finance Supervisory Div.

The appointment of Osamu Okuda as Chairman of the Board of Directors is subject to approval at the Board of Directors Meeting, which is scheduled to be convened on March 29, 2022.
The appointment of Hisafumi Yamada and Toshiaki Itagaki as Directors is subject to approval at the 111th Annual General Meeting of Shareholders, which is scheduled to be convened on March 29, 2022.
Tatsuro Kosaka is scheduled to retire from Representative Director, Chairman as of March 29, 2022 to be appointed as Senior Advisor.
Motoo Ueno is scheduled to retire from Representative Director, Deputy Chairman as of March 29, 2022 to be appointed as Senior Advisor.

Executive Officers

Name	New Responsibilities	Current Responsibilities
Shinya Unno	Deputy President Special Mission for CEO	Deputy President Supervisory responsibility for Human Resources Management, Legal, Intellectual Property and General Affairs In charge of General Affairs Dept.
Tetsuya Yamaguchi	Executive Vice President Supervisory responsibility for Project & Lifecycle Management (Marketing), Drug Safety, Medical Affairs and Foundation Medicine Head of Project & Lifecycle Management Unit	Executive Vice President Supervisory responsibility for Project & Lifecycle Management (Marketing), Corporate Planning, Quality & Regulatory Compliance Head of Project & Lifecycle Management Unit In charge of Corporate Planning Dept.
Junichi Ebihara	Senior Vice President Supervisory responsibility for Legal, Intellectual Property, General Affairs, Risk Management, Compliance, and Quality & Regulatory Compliance In charge of Legal Dept., Intellectual Property Dept., and General Affairs Dept.	Senior Vice President In charge of Legal Dept. and Intellectual Property Dept.
Shinji Hidaka	Vice President Supervisory responsibility for Marketing & Sales Head of Marketing & Sales Div.	Vice President Head of Marketing & Sales Div.
Yoshiyuki Yano	Vice President Supervisory responsibility for Human Resource Management and EHS Head of Human Resources Management Dept. In charge of Sustainability Dept.	Vice President Head of Human Resources Management Dept.
Satoko Shisai	Vice President Supervisory responsibility for Digital Transformation Head of Digital Transformation Unit	Vice President Head of Digital Transformation Unit

Effective April 1, 2022

Executive Officers

Name	New Responsibilities	Current Responsibilities
Shinji Hidaka	Executive Vice President Supervisory responsibility for Marketing & Sales Head of Marketing & Sales Div.	Vice President Supervisory responsibility for Marketing & Sales Head of Marketing & Sales Div.
Yoshiyuki Yano	Executive Vice President Supervisory responsibility for Human Resource Management and EHS Head of Human Resources Management Dept. In charge of Sustainability Dept.	Vice President Supervisory responsibility for Human Resource Management and EHS Head of Human Resources Management Dept. In charge of Sustainability Dept.
Satoko Shisai	Executive Vice President Supervisory responsibility for Digital Transformation Head of Digital Transformation Unit	Vice President Supervisory responsibility for Digital Transformation Head of Digital Transformation Unit
Hitoshi Iikura	Vice President Head of Research Div.	Head of Research Div.
Masayoshi Higuchi	Vice President Head of Quality & Regulatory Compliance Unit	Head of Quality & Regulatory Compliance Unit

Shinya Unno and Hiroyuki Matsumoto are scheduled to retire from Executive Officers as of March 31, 2022.

[PDF 491KB]

Contact:

For Media
Chugai Pharmaceutical Co., Ltd.
Media Relations Group, Corporate Communications Dept.,
Tomoko Shimizu
Tel: +81-3-3273-0881
E-mail: pr@chugai-pharm.co.jp

For Investors
Chugai Pharmaceutical Co., Ltd.
Investor Relations Group, Corporate Communications Dept.,
Takayuki Sakurai
Tel: +81-3-3273-0554
E-mail: ir@chugai-pharm.co.jp

Back